Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging

Radiology

Volumn 260, Issue 3, 2011, Pages 727-733

  Yamada, Akira ^a,b   Hara, Takeshi ^a   Li, Feng ^a   Fujinaga, Yasunari ^b   Ueda, Kazuhiko ^b   Kadoya, Masumi ^b   Doi, Kunio ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FAT SUPPRESSION TECHNIQUE; FEMALE; HEPATOBILIARY PARAMETERS; HEPATOCELLULAR UPTAKE INDEX; HUMAN; IMAGE ANALYSIS; IRON STORAGE; LIPID STORAGE; LIVER FUNCTION TEST; LIVER SIZE; LIVER WEIGHT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PLASMA CLEARANCE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SPLEEN SIZE; T1 WEIGHTED IMAGING; THREE DIMENSIONAL IMAGING;

AGED, 80 AND OVER; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84860389920     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11100586     Document Type: Article

References (29)

1. Seyama Y., Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res 2009;39(2):107-116.
2. Sakka S.G. Assessing liver function. Curr Opin Crit Care 2007;13(2):207-214. (Pubitemid 46328337)
3. Reimer P., Schneider G., Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: Properties, clinical development and applications. Eur Radiol 2004;14(4):559-578. (Pubitemid 38444568)
4. Clément O., Mühler A., Vexler V., Berthezène Y., Brasch R.C. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent: Kinetic and enhancement patterns in normal and cholestatic rats. Invest Radiol 1992;27(8):612-619.
5. Meier P.J., Eckhardt U., Schroeder A., Hagenbuch B., Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 1997;26(6):1667-1677. (Pubitemid 27520039)
6. Shimizu J., Dono K., Gotoh M., et al. Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging. Dig Dis Sci 1999;44(7):1330-1337. (Pubitemid 29404293)
7. Schmitz S.A., Mühler A., Wagner S., Wolf K.J. Functional hepatobiliary imaging with gadolinium-EOB-DTPA: A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats. Invest Radiol 1996;31(3):154-160.
8. Kim T., Murakami T., Hasuike Y., et al. Experimental hepatic dysfunction: Evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 1997;7(4):683-688. (Pubitemid 28365618)
9. Nilsson H., Nordell A., Vargas R., Douglas L., Jonas E., Blomqvist L. Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI. J Magn Reson Imaging 2009;29(6):1323-1331.
10. Ryeom H.K., Kim S.H., Kim J.Y., et al. Quantitative evaluation of liver function with MRI using Gd-EOB-DTPA. Korean J Radiol 2004;5(4):231-239.
11. Motosugi U., Ichikawa T., Tominaga L., et al. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: Is it possible to shorten the examination time? Eur Radiol 2009;19(11):2623-2629.
12. Moody F.G., Rikkers L.F., Aldrete J.S. Estimation of the functional reserve of human liver. Ann Surg 1974;180(4):592-598.
13. Gandon Y., Olivié D., Guyader D., et al. Noninvasive assessment of hepatic iron stores by MRI. Lancet 2004;363(9406):357-362. (Pubitemid 38169542)
14. Rinella M.E., McCarthy R., Thakrar K., et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation. Liver Transpl 2003;9(8):851-856. (Pubitemid 36974953)
15. Martinez W., Martinez A. Bootstrap methods. In: Computational statistics handbook with MATLAB. 2nd ed. Boca Raton, Fla : Chapman & Hall/CRC, 2007;256-262.
16. Malhi H., Gores G.J. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008;134(6):1641-1654. (Pubitemid 351615416)
17. Van Beers B.E., Materne R., Annet L., et al. Capillarization of the sinusoids in liver fibrosis: Noninvasive assessment with contrastenhanced MRI in the rabbit. Magn Reson Med 2003;49(4):692-699. (Pubitemid 36389979)
18. Tsuda N., Okada M., Murakami T. New proposal for the staging of nonalcoholic steatohepatitis: Evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 2010;73(1):137-142.
19. Runge V.M. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr 1998;22(4):643-650. (Pubitemid 28433803)
20. Kötz B., West C., Saleem A., Jones T., Price P. Blood flow and Vd (water): Both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue. Mol Cancer Ther 2009;8(2):303-309.
21. Van Beers B.E., Leconte I., Materne R., Smith A.M., Jamart J., Horsmans Y. Hepatic perfusion parameters in chronic liver disease: Dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001;176(3):667-673. (Pubitemid 32181963)
22. Hagiwara M., Rusinek H., Lee V.S., et al. Advanced liver fibrosis: Diagnosis with 3D whole-liver perfusion MR imaging - initial experience. Radiology 2008;246(3):926-934.
23. Schuhmann-Giampieri G., Schmitt-Willich H., Press W.R., Negishi C., Weinmann H.J., Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183(1):59-64.
24. Cavalli G., Re G., Casali A.M. Red pulp arterial terminals in congestive splenomegaly. A morphometric study. Pathol Res Pract 1984;178(6):590-594. (Pubitemid 14030284)
25. Kaufman S., Levasseur J. Effect of portal hypertension on splenic blood flow, intraplenic extravasation and systemic blood pressure. Am J Physiol Regul Integr Comp Physiol 2003;284(6):R1580-R1585. (Pubitemid 36617499)
26. Hashimoto M., Watanabe G. Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res 2000;92(2):222-227. (Pubitemid 30612634)
27. Zhou X.P., Lu T., Wei Y.G., Chen X.Z. Liver volume variation in patients with virus-induced cirrhosis: Findings on MDCT. AJR Am J Roentgenol 2007;189(3):W153-W159.
28. Nanashima A., Yamaguchi H., Shibasaki S., et al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patient outcome. Hepatol Res 2004;28(4):184-190. (Pubitemid 38351912)
29. Suda K., Ohtsuka M., Ambiru S., et al. Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies. Am J Surg 2009;197(6):752-758.